Entera Bio Ltd

NASDAQ:ENTX   3:59:41 PM EDT
1.68
-0.08 (-4.54%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Entera Bio Ltd. Stock, NASDAQ:ENTX

KIRYAT HADASSAH, MINRAV BUILDING, FIFTH FLOOR, JERUSALEM, ISRAEL 9112002
Israel
Phone: 972-2-532-7151
Number of Employees:

Description

Entera Bio Ltd., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of orally delivered large molecule therapeutics for unmet medical needs. The company's lead product includes the EB612, an oral parathyroid hormone product candidate that has completed a Phase IIa clinical trial for hypoparathyroidism. It is also developing EB613 that has completed Phase I clinical trials for the treatment of osteoporosis and non-union fractures. The company was founded in 2010 and is headquartered in Jerusalem, Israel.